Trading window closed from July 1 ahead of Q1 results

EMCURE · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close

-0.5%1-day move

₹1842.50

prior close

₹1860.00

base price

After-mkt

timing

5m10m15m30m1D2D3D4D5D7D15D1M2M3M

-0.8-0.6-0.3-0.6-0.5+0.9+0.2-0.4+0.1-1.8+4.8———

Up moveDown movePending

AI summary

Emcure Pharmaceuticals has informed exchanges that its insider trading window will be shut from Wednesday, July 1, 2026, until 48 hours after the company declares its unaudited financial results for the quarter ending June 30, 2026 (Q1 FY27). Designated persons and their immediate relatives cannot trade in the stock during this period. The Board meeting date to approve the Q1 results will be announced later. This is a routine compliance step required under SEBI insider trading rules before quarterly earnings.

Likely market impact

Routine compliance filing. Signals upcoming Q1 results announcement. Watch for board meeting date intimation in coming weeks.